Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;16(4):420-424.
doi: 10.1097/ADM.0000000000000924.

Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy

Isabelle Mason  1 , Sarah Mashburn, Erin Cleary, Mahmoud Abdelwahab, Marwan Ma'ayeh, Kara M Rood
Affiliations

Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy

Isabelle Mason et al. J Addict Med. 2022 Jul-Aug.

Abstract

Background: Untreated opioid misuse in pregnancy is associated with adverse outcomes. Limited information is available on maternal and perinatal outcomes in subsequent pregnancies for individuals initiated on medication for opioid use disorder (MOUD) in a prior pregnancy.

Objective: Evaluate maternal and neonatal outcomes in subsequent pregnancies for individuals initiated on MOUD in prior pregnancy.

Methods: Historical cohort study including individuals with opioid use disorder with ≥2 pregnancies between 2013 and 2020, received care in our colocated multidisciplinary clinic for >1 pregnancy, and delivered at our institution. Primary outcome was rate of preconception MOUD. Secondary outcomes included rate of neonatal opioid withdrawal syndrome requiring pharmacologic treatment and length of hospital stay.

Results: Forty-two individuals with opioid use disorder in their index pregnancies (n = 42) and 46 subsequent pregnancies were identified. Individuals were more likely to receive long-acting reversible contraception in subsequent pregnancies (35% vs 14%, P = 0.04). No differences in tobacco use, gestational age at initiation of prenatal care or delivery was noted. Individuals in their subsequent pregnancies were 6 times more likely to be on MOUD preconception (78% vs 36%; OR, 6.48; [95% CI, 2.52-16.64]) and 67% less likely to have positive illicit urine drug screen upon initiation of care (36% vs 64%; OR, 0.33; 95% [CI, 0.14-0.78]). Neonates had similar rates of neonatal abstinence withdrawal syndrome requiring pharmacological treatment, positive illicit toxicology results, and neonatal length of stay.

Conclusions: Participation in multidisciplinary obstetric and opioid use disorder program increases rate of MOUD in subsequent pregnancy with decrease in illicit drug use.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Comment in

References

    1. Haight SC, Ko JY, Tong VT, et al. Opioid use disorder documented at delivery hospitalization-United States, 1999–2014. MMWR Morb Mortal Wkly Rep. 2018;67(31);845–849.
    1. Hall OT, Hall OE, McGrath RP, et al. Years of life lost due to opioid overdose in Ohio: Temporal and geographic patterns of excess mortality. J Addict Med. 2020;14(2):156–162.
    1. Prasad M, Jones M. Medical complications of opioid use disorder in pregnancy. Semin Perinatol. 2019;43(3):162–167.
    1. Maeda A, Bateman BT, Clancy CR, et al. Opioid abuse and dependence during pregnancy: Temporal trends and obstetrical outcomes. Anesthesi-ology. 2014;121(6):1158–1165.
    1. Larson JJ, Graham DL, Singer LT, et al. Cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics. 2019;144(2):e20190514

MeSH terms